Roche Secures Dicerna RNAi Deal For Hepatitis B

Roche Pays $200m Up Front For DCR-HBVS Candidate

 
• By Alexandra Shimmings
  
Hepatitis B
Hepatitis B Virus • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip